AstraZeneca Pharma India PAT at Rs 11.94 cr. in Q2FY22
The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Cryoballoon catheter ablation, a minimally invasive procedure, is one of the therapeutic modalities to manage Atrial fibrillation
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The Board of Directors of Wockhardt have approved the unaudited consolidated financial results for the period ended September 30, 2021.
The Board of Directors of Aurobindo Pharma have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Subscribe To Our Newsletter & Stay Updated